CTFA Weighs In As Prop 65 Amicus Brief Filed In Calif. Supreme Court
This article was originally published in The Rose Sheet
Executive Summary
The Cosmetic, Toiletry and Fragrance Association amicus curiae brief in defense of nicotine-replacement therapy manufacturers involved in California Prop 65 litigation reflects the group's concern the labeling conflict involved could extend to other OTC drugs
You may also be interested in...
German Firm Hopes To Drill Into U.S. Market With Anti-Dandruff Ingredient
Dermatology ingredient manufacturer Ichthyol-Gesellschaft is looking to introduce sodium shale oil sulfonate into FDA's OTC monograph as an ingredient that is generally recognized as safe and effective in treating dandruff
German Firm Hopes To Drill Into U.S. Market With Anti-Dandruff Ingredient
Dermatology ingredient manufacturer Ichthyol-Gesellschaft is looking to introduce sodium shale oil sulfonate into FDA's OTC monograph as an ingredient that is generally recognized as safe and effective in treating dandruff
Calif. Supreme Court Rules In Favor Of Glaxo, FDA On Prop 65 Warnings
State regulations that conflict with FDA drug labeling are preempted by federal law, the California Supreme Court ruled April 15 in a case challenging the state's mandatory Prop 65 warning requirements for nicotine replacement therapy (NRT) products